The STXBP1 gene is associated with autosomal dominant early infantile epileptic encephalopathy (EIEE) (MedGen UID: 436917).
Order this gene as a single gene test.
STXBP1: Deletion/duplication analysis is not offered for exons 1-3.
Invitae tests that include this gene:
Pathogenic variants in the STXBP1 gene are associated with ~35% of clinical cases of Ohtahara syndrome (early infantile epileptic encephalopathy (EIEE)).
The STXBP1 gene encodes a protein that interacts with vesicle membrane proteins and participates in vesicle trafficking and exocytosis, including neurotransmitter release at synapses.
Invitae is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory performing full-gene sequencing and deletion/duplication analysis using next-generation sequencing technology (NGS).
Our sequence analysis covers clinically important regions of each gene, including coding exons, +/- 10 base pairs of adjacent intronic sequence, and select noncoding variants. Our assay provides a Q30 quality-adjusted mean coverage depth of 350x (50x minimum, or supplemented with additional analysis). Variants classified as pathogenic or likely pathogenic are confirmed with orthogonal methods, except individual variants that have high quality scores and previously validated in at least ten unrelated samples.
Our analysis detects most intragenic deletions and duplications at single exon resolution. However, in rare situations, single-exon copy number events may not be analyzed due to inherent sequence properties or isolated reduction in data quality. If you are requesting the detection of a specific single-exon copy number variation, please contact Client Services before placing your order.
|Gene||Transcript reference||Sequencing analysis||Deletion/Duplication analysis|
*STXBP1: Deletion/duplication analysis is not offered for exons 1-3.